MAP (health technology and life science)

MAP Biotech is an Australian developer and provider of scientifically validated applications, digital therapeutics, and cloud technologies that measure and improve psychosocial wellbeing.
MAP Biotech was founded by Zephyr Bloch-Jorgensen in 2010 and is responsible for the development and scientific evaluation of centeredness theory.
The three cornerstones of its operations center around the life sciences, digital technology, and deep data analytics.
MAP Biotech provides tools and services aligning with the second-wave positive psychology movement and trends in public health that deviate from a traditional focus on pathology and risk factors.
These resources target the development of individual qualities and a personal life that promotes centeredness (self-actualization) rather than simply negating mental illness, supporting the upper end of the wellbeing spectrum.
Its mission is to democratize wellbeing and make self-actualization (conceptualized as centeredness) an egalitarian reality.
MAP Biotech has supported contributions to basic and clinical research in the fields of behavioral and cognitive neuroscience, psychiatry, and public mental health, and continues to forward research and discoveries in the areas of human potential and wellbeing according to the principles of centeredness theory.
In the book, Bloch-Jorgensen put forward a conceptualization of centeredness and drew on principles from philosophy, spirituality, psychology, and the natural sciences to define a new paradigm for mental health and wellbeing. In 2012, MAP released V1 of Meta-Analysis Profile (MAP), featuring a 60-item assessment of centeredness.
This assessment was scientifically validated with user responses from 38 countries in collaboration with the not-for-profit research institute NeuRA,
The publication of the research also empirically evidenced the theoretical principles of centeredness theory-the underpinning for MAP’s tools and services. Given this, further technologies, licenses, services, and collaborative initiatives generated by MAP were developed based on centeredness theory’s principles, which are proposed to have wide-ranging applications at micro (individual), meso (group), and macro (global) levels.
Central among these was the application of the centeredness theory framework to work with traumatic brain injury and aphasia by researchers and clinical practitioners at the University of Kentucky and the U.S. Center for Disease Control (“CDC”).
The theory has been used in this setting to guide the development of a motivational interviewing schedule, which explores life aspects that are important to patients and interact across the theory’s five domains as part of a ‘life participation approach’ to managing aphasia (LPAA).

Main Menu

See Also

Main Menu